Kantoff Philip W. 4
4 · Context Therapeutics Inc. · Filed May 31, 2023
Insider Transaction Report
Form 4
Kantoff Philip W.
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-31+25,000→ 25,000 totalExercise: $0.87Exp: 2033-05-30→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.